- Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan
-
Hatano M, Takeuchi I, Yamashita K, Morita A, Tozawa K, Sakakibara T, Hajitsu G, Hanya M, Yamada S, Iwata N, Kamei H
- KMID: 2522958
- Clin Psychopharmacol Neurosci.
- 2021 Nov;19(4):610-617.
- doi: 10.9758/cpn.2021.19.4.610
Objective: To identify factors affecting adherence to medication, a subjective questionnaire survey was administered to schizophrenia patients regarding the prescribed antipsychotic formulations. Methods: We evaluated the patients’ satisfaction and dissatisfaction with... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Effect of Mirogabalin on Peripheral Neuropathic Pain due to Lumbar Spine Disease
-
Kim K, Isu T, Kokubo R, Iwamoto N, Morimoto D, Kawauchi M, Morita A
- KMID: 2516781
- Asian Spine J.
- 2021 Jun;15(3):349-356.
- doi: 10.31616/asj.2020.0136
Study Design Retrospective study. Purpose This study aims to evaluate the effectiveness of mirogabalin in treatment of peripheral neuropathic pain due to lumbar spine disease. Overview of Literature Mirogabalin is a novel selective ligand for... -
- CITED
-
- Close
- SHARE
-
- Close
- External Validation of the ELAPSS Score for Prediction of Unruptured Intracranial Aneurysm Growth Risk
-
van Kammen MS, Greving JP, Kuroda S, Kashiwazaki D, Morita A, Shiokawa Y, Kimura T, Cognard C, Januel AC, Lindgren A, Koivisto T, Jääskeläinen JE, Ronkainen , Pyysalo L, Öhman J, Rahi M, Kuhmonen J, Rinne J, Leemans EL, Majoie CB, Vandertop , Verbaan D, Roos YB, van den Berg R, Boogaarts , Moudrous W, van den Wijngaard IR, Hove LT, Teo M, St George , Hackenberg KAM, Abdulazim , Etminan N, Rinkel GJ, Vergouwen
- KMID: 2464651
- J Stroke.
- 2019 Sep;21(3):340-346.
- doi: 10.5853/jos.2019.01277
BACKGROUND AND PURPOSE: Prediction of intracranial aneurysm growth risk can assist physicians in planning of follow-up imaging of conservatively managed unruptured intracranial aneurysms. We therefore aimed to externally validate the... -
- CITED
-
- Close
- SHARE
-
- Close
